Integrated transcriptomic analysis identifies an AKT1-associated metabolic-inflammatory signature in osteoporosis.
- 1Guizhou University Medical College, Guiyang, 550025, Guizhou, China. [email protected].
- 2Liangzhu Laboratory, 5A, Building 4, Cangqian Street, Hangzhou, 311113, Zhejiang, China. [email protected].
- 3Liangzhu Laboratory, MOE Frontier Science Center for Brain Science and Brain-Machine Integration, State Key Laboratory of Brain-Machine Intelligence, Zhejiang University, Hangzhou, China.
Abstract
Osteoporosis is a significant global health challenge, and low bone mineral density (Low-BMD) is a major clinical feature and risk indicator of osteoporosis. Fatty acid metabolism has been increasingly implicated in bone remodeling and inflammatory regulation, but the transcriptomic links between fatty acid metabolism and immune-inflammatory alterations in Low-BMD remain unclear. We integrated three GEO datasets, including 60 High-BMD controls and 59 Low-BMD subjects. Differential expression analysis, immune infiltration analysis, NMF clustering, WGCNA, pseudotime analysis, and machine learning were performed to identify fatty acid metabolism-related genes associated with Low-BMD. AKT1 knockdown was used to evaluate its potential role in regulating inflammatory mediators. Eighteen fatty acid metabolism-related differentially expressed genes were identified between High-BMD and Low-BMD samples and were enriched in inflammatory, immune, and osteoclast-related pathways. NMF clustering revealed two Low-BMD molecular subtypes with distinct metabolic and immune-inflammatory features. Machine learning identified an AKT1-containing diagnostic signature with good predictive performance, and AKT1 was positively correlated with inflammatory response scores and inflammatory markers. Quantitative Real-time PCR confirmed Akt1 knockdown, and ELISA showed reduced IL-6, TNF-α, and IL-1β secretion in MC3T3-E1 cells. AKT1 may serve as a fatty acid metabolism-related candidate gene associated with immune-inflammatory remodeling and inflammatory mediator regulation in Low-BMD. These findings suggest a potential AKT1-associated metabolic-inflammatory regulatory relationship and provide candidate biomarkers for future validation in osteoporosis-related bone loss.
Related
- Integrated Spatial and Bulk Transcriptomic Analysis Identifies a Multicellular Ecosystem Involved in Progression of Young Breast Cancer.
- Integrated analysis of transcriptomic and proteomic profiles identifies divergent regulatory networks for intramuscular fat in Chinese versus Western Pigs
- Clinical, single-cell, and spatial transcriptomic integration identifies an RCD-high inflammatory myeloid program for early neurological deterioration and outcome stratification after acute ischemic stroke
- Integrated toxicogenomic and single-nucleus transcriptomic analyses prioritize SDHB and NDUFAB1 in mitochondrial respiration-associated remodeling during cisplatin-induced acute kidney injury
- Multi-omics analysis identifies ANXA2-associated transcriptomic and splicing networks in osteoblast proliferation and apoptosis
BibTeX
@article{bao2026integrated,
title = {{Integrated transcriptomic analysis identifies an AKT1-associated metabolic-inflammatory signature in osteoporosis.}},
author = {Chenglong Bao and Ronggui Hu},
journal = {Clinical and experimental medicine},
year = {2026},
month = jul,
doi = {10.1007/s10238-026-02263-8},
url = {https://europepmc.org/article/MED/42905181},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Integrated transcriptomic analysis identifies an AKT1-associated metabolic-inflammatory signature in osteoporosis.
AU - Chenglong Bao
AU - Ronggui Hu
PY - 2026
DA - 2026/07/25
JO - Clinical and experimental medicine
DO - 10.1007/s10238-026-02263-8
UR - https://europepmc.org/article/MED/42905181
AB - Osteoporosis is a significant global health challenge, and low bone mineral density (Low-BMD) is a major clinical feature and risk indicator of osteoporosis. Fatty acid metabolism has been increasingly implicated in bone remodeling and inflammatory regulation, but the transcriptomic links between fatty acid metabolism and immune-inflammatory alterations in Low-BMD remain unclear. We integrated three GEO datasets, including 60 High-BMD controls and 59 Low-BMD subjects. Differential expression analysis, immune infiltration analysis, NMF clustering, WGCNA, pseudotime analysis, and machine learning were performed to identify fatty acid metabolism-related genes associated with Low-BMD. AKT1 knockdown was used to evaluate its potential role in regulating inflammatory mediators. Eighteen fatty acid metabolism-related differentially expressed genes were identified between High-BMD and Low-BMD samples and were enriched in inflammatory, immune, and osteoclast-related pathways. NMF clustering revealed two Low-BMD molecular subtypes with distinct metabolic and immune-inflammatory features. Machine learning identified an AKT1-containing diagnostic signature with good predictive performance, and AKT1 was positively correlated with inflammatory response scores and inflammatory markers. Quantitative Real-time PCR confirmed Akt1 knockdown, and ELISA showed reduced IL-6, TNF-α, and IL-1β secretion in MC3T3-E1 cells. AKT1 may serve as a fatty acid metabolism-related candidate gene associated with immune-inflammatory remodeling and inflammatory mediator regulation in Low-BMD. These findings suggest a potential AKT1-associated metabolic-inflammatory regulatory relationship and provide candidate biomarkers for future validation in osteoporosis-related bone loss.
SN - 1591-8890
SN - 1591-9528
ER -